BNR
Burning Rock Biotech Ltd.
NASDAQ · Healthcare · Medical - Diagnostics & Research · CN
$10.80
−2.26%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.33x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.53x
- Price / sales
- 1.52x
- Price / cash flow
- -62.11x
Enterprise value
- Enterprise value
- $57.8M
- EV / sales
- 0.77x
- EV / EBITDA
- -9.12x
- EV / EBIT
- -5.92x
- Market cap
- $113.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026